New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

New Blood Test Assesses Leukemia Risk

The diagnostic test aims to determine the risk of developing leukemia by identifying changes in blood cell production.

Screen Shot 2022 07 26 At 7 39 39 Am

As people advance in age, they become more prone to mutations in blood stem cells that can disrupt the balance of blood cells in the body, which is linked to leukemia. According to a recent Healthcare in Europe article, scientists at the Universities of Edinburgh and Glasgow monitored these changes over a 12 year period to better understand what they mean in the context of developing leukemia as people grow older.

The data was combined with an algorithm to link various mutations with different growth speeds of blood stem cells that carry mutations, to determine leukemia risk. Knowing a person’s risk of developing leukemia allows clinicians to schedule screening appointments with better pacing that hopefully leads to earlier detection and treatment.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub